Covering: up to 2010 The myxobacteria, long a source of fascination due to their sophisticated, social lifestyles, are now increasingly recognized as multi-producers of promising natural products. Here we provide an overview of the bioactivities and modes-of-action of these secondary metabolites, with an emphasis on potential clinical applications.
No takes yet. Share an insight, caveat, or question.
Weissman et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: